NEJM Interview: Heather Hsu on an institutional conference series that provides opportunities for addressing the adverse effects of bias and medical racism.

The Marburg Virus Outbreak in Rwanda

NEJM Interview: Vincent Guilamo-Ramos on the need to rethink the response to HIV in Latino communities.

NEJM Interview: Liam McCoy on concerns about the implementation of large language models in note writing and related clinical tasks.

NEJM Interview: Mark Wicclair on approaches to protecting both physicians’ conscience and patients’ health.

NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity.

NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern.

NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform.

NEJM Interview: Abigail Cutler on providing training in abortion care to Ob/Gyn residents amid legal restrictions.

NEJM Interview: Charles Weijer on the potential benefits and ethical challenges associated with pragmatic and cluster RCTs.

NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma

NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors

NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer

NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

NEJM at ESMO — Ponsegromab in Cancer Cachexia

NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer

NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer